Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC vs GSK PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC GSK PHARMA ALEMBIC/
GSK PHARMA
 
P/E (TTM) x 28.2 62.2 45.2% View Chart
P/BV x 1.0 18.9 5.5% View Chart
Dividend Yield % 2.6 1.6 159.7%  

Financials

 ALEMBIC   GSK PHARMA
EQUITY SHARE DATA
    ALEMBIC
Mar-23
GSK PHARMA
Mar-23
ALEMBIC/
GSK PHARMA
5-Yr Chart
Click to enlarge
High Rs871,684 5.2%   
Low Rs561,231 4.5%   
Sales per share (Unadj.) Rs5.0191.9 2.6%  
Earnings per share (Unadj.) Rs3.135.9 8.8%  
Cash flow per share (Unadj.) Rs3.439.8 8.6%  
Dividends per share (Unadj.) Rs2.2032.00 6.9%  
Avg Dividend yield %3.12.2 140.6%  
Book value per share (Unadj.) Rs80.9102.9 78.7%  
Shares outstanding (eoy) m256.78169.41 151.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x14.47.6 189.4%   
Avg P/E ratio x22.740.6 55.9%  
P/CF ratio (eoy) x21.036.7 57.2%  
Price / Book Value ratio x0.914.2 6.2%  
Dividend payout %70.189.2 78.5%   
Avg Mkt Cap Rs m18,298246,858 7.4%   
No. of employees `000NANA-   
Total wages/salary Rs m2405,950 4.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m1,27232,517 3.9%  
Other income Rs m6431,007 63.8%   
Total revenues Rs m1,91533,524 5.7%   
Gross profit Rs m2978,033 3.7%  
Depreciation Rs m67658 10.2%   
Interest Rs m518 25.7%   
Profit before tax Rs m8688,364 10.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m622,288 2.7%   
Profit after tax Rs m8066,076 13.3%  
Gross profit margin %23.424.7 94.6%  
Effective tax rate %7.127.4 26.0%   
Net profit margin %63.418.7 339.1%  
BALANCE SHEET DATA
Current assets Rs m1,72124,943 6.9%   
Current liabilities Rs m83813,264 6.3%   
Net working cap to sales %69.435.9 193.3%  
Current ratio x2.11.9 109.2%  
Inventory Days Days5,03897 5,178.4%  
Debtors Days Days673216 311.5%  
Net fixed assets Rs m20,3246,988 290.9%   
Share capital Rs m5141,694 30.3%   
"Free" reserves Rs m20,26715,735 128.8%   
Net worth Rs m20,78017,430 119.2%   
Long term debt Rs m00-   
Total assets Rs m22,04631,930 69.0%  
Interest coverage x187.7462.6 40.6%   
Debt to equity ratio x00-  
Sales to assets ratio x0.11.0 5.7%   
Return on assets %3.719.1 19.3%  
Return on equity %3.934.9 11.1%  
Return on capital %4.248.1 8.7%  
Exports to sales %1.20-   
Imports to sales %2.448.1 4.9%   
Exports (fob) Rs m16NA-   
Imports (cif) Rs m3015,630 0.2%   
Fx inflow Rs m161,622 1.0%   
Fx outflow Rs m3015,630 0.2%   
Net fx Rs m-14-14,008 0.1%   
CASH FLOW
From Operations Rs m3894,842 8.0%  
From Investments Rs m738,079 0.9%  
From Financial Activity Rs m-464-15,433 3.0%  
Net Cashflow Rs m-2-2,512 0.1%  

Share Holding

Indian Promoters % 70.9 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 0.9 11.6 8.1%  
FIIs % 0.9 2.9 30.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 25.0 116.5%  
Shareholders   94,012 114,663 82.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on ALEMBIC vs GSK Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ALEMBIC vs GSK Pharma Share Price Performance

Period ALEMBIC GSK Pharma S&P BSE HEALTHCARE
1-Day 4.34% 3.26% 1.18%
1-Month -14.48% -9.77% -0.75%
1-Year 48.73% 52.63% 61.82%
3-Year CAGR -6.26% 10.89% 18.16%
5-Year CAGR 14.97% 8.44% 19.79%

* Compound Annual Growth Rate

Here are more details on the ALEMBIC share price and the GSK Pharma share price.

Moving on to shareholding structures...

The promoters of ALEMBIC hold a 70.9% stake in the company. In case of GSK Pharma the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ALEMBIC and the shareholding pattern of GSK Pharma.

Finally, a word on dividends...

In the most recent financial year, ALEMBIC paid a dividend of Rs 2.2 per share. This amounted to a Dividend Payout ratio of 70.1%.

GSK Pharma paid Rs 32.0, and its dividend payout ratio stood at 89.2%.

You may visit here to review the dividend history of ALEMBIC, and the dividend history of GSK Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.